05:42 PM EDT, 05/01/2025 (MT Newswires) -- Exact Sciences ( EXAS ) reported a Q1 adjusted net loss late Thursday of $0.21 per diluted share, narrowing a loss of $0.37 a year earlier.

Analysts polled by FactSet expected a loss of $0.25.

Revenue for the quarter ended March 31 was $706.8 million, up from $637.5 million a year earlier. Analysts forecast sales of $688.6 million.

For full-year 2025, the company raised its revenue guidance to a range of $3.07 billion to $3.12 billion from $3.03 billion to $3.09 billion. Analysts expect $3.05 billion.

Shares are up more than 8.5% in recent after-hours activity.